BioCentury | Sep 21, 2018
Company News

Roivant launches respiratory vant, announces other vant news

...and Patara CEO Bill Gerhart will serve as CEO for the Roivant subsidiary. RVT-1601 is G protein-coupled receptor 35 (GPR35)...
BioCentury | Sep 17, 2018
Company News

Roivant launches respiratory vant, announces other vant news

...and Patara CEO Bill Gerhart will serve as CEO for the Roivant subsidiary. RVT-1601 is G protein-coupled receptor 35 (GPR35)...
BioCentury | Sep 19, 2016
Clinical News

PA101: Phase II data

...Inc. , San Diego, Calif. Product: PA101 (formerly PA101B) Business: Pulmonary Molecular target: G protein-coupled receptor 35 (GPR35) Description: G protein-coupled receptor 35 (GPR35)...
BioCentury | Oct 19, 2015
Clinical News

PA101B: Phase II started

...Patara Pharma Inc. , San Diego, Calif. Product: PA101B Business: Pulmonary Molecular target: G protein-coupled receptor 35 (GPR35) Description: G protein-coupled receptor 35 (GPR35)...
BioCentury | Oct 19, 2015
Clinical News

PA101B: Phase II started

...Patara Pharma Inc. , San Diego, Calif. Product: PA101B Business: Hematology Molecular target: G protein-coupled receptor 35 (GPR35) Description: G protein-coupled receptor 35 (GPR35)...
BioCentury | Oct 13, 2015
Financial News

Patara raises $26M, starts Phase II studies

...round and began two Phase II trials of PA101B , an agonist of G protein-coupled receptor 35 ( GPR35...
Items per page:
1 - 6 of 6